CNBX Patent Application “Composition and Method for Treating Cancer with Cannabinoids” Enters National Phase in US and Israel

October 13, 2022

Moleculin to Present at 38th Annual ROTH Conference

March 17, 2026
Clearmind Medicine Announces Publication of Six Innovative Patents in Hong Kong for Next-Generation Psychedelic-Based Combination Therapies

March 17, 2026
SciSparc: NeuroThera Labs- Clearmind Medicine Collaboration Leads to Patent Application for Depression Therapy

March 16, 2026
Akari Therapeutics Releases CEO Corner Highlighting Strategic Progress and Path to Clinical Development Under CEO Abizer Gaslightwala

March 13, 2026